Benjamin Albert notifies sale of 4,966 restricted HCAT shares (NASDAQ: HCAT)

Rhea-AI Filing Summary

Benjamin Albert submitted a Form 144 reporting an intended sale of restricted common stock of Health Catalyst, Inc. on 03/02/2026. The filing lists 4,966 shares in connection with broker Morgan Stanley Smith Barney LLC and shows a prior sale of 13,304 shares on 02/26/2026.

Insights

Securities Compliance Officer

Form 144 notifies an intended insider sale; reporting details and recent sales are disclosed.

The filing lists an intended sale of restricted common stock of Health Catalyst, Inc. dated 03/02/2026 with 4,966 shares tied to Morgan Stanley Smith Barney LLC. It also records a sale of 13,304 shares on 02/26/2026.

These disclosures meet routine reporting obligations under resale rules; actual execution, settlement, and any proceeds are determined by subsequent transactions and are not shown in the excerpt.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 07:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	4966	8243.06	70730884	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Restricted Stock	Health Catalyst, Inc.			4966	03/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	02/26/2026	13304	23252.73

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

Who filed the Form 144 for HCAT?

Benjamin Albert filed the Form 144. The filing lists his intended sale of restricted common stock of Health Catalyst, Inc. with an identified broker on 03/02/2026.

How many HCAT shares are listed for sale on the Form 144?

The Form 144 lists an intended sale of 4,966 restricted shares of Health Catalyst, Inc. on 03/02/2026. This number appears in the filing's securities-to-be-sold section.

Were there recent HCAT sales by the same filer?

Yes; the filing records a prior sale of 13,304 restricted shares dated 02/26/2026. That sale is shown in the "securities sold during the past 3 months" section.

Which broker is named in the Form 144 for HCAT transactions?

Morgan Stanley Smith Barney LLC is listed as the broker on the filing. The broker's New York address appears alongside the securities-to-be-sold details.

Does the Form 144 show proceeds or execution status for the sale?

The excerpt does not show sale proceeds or whether the intended sale executed. The filing lists intended sale details but does not report settlement or cash amounts for the March transaction.